John Armitage - Egerton Capital – Largest Position Reductions (2026 Q1)
This report summarizes the most meaningful reductions and sell-offs made by John Armitage - Egerton Capital in 2026 Q1. The analysis highlights which positions were trimmed or exited, providing insight into how the investor adjusted risk exposure and portfolio strategy.
| Symbol | Shares | Reported Price(USD) | Action | Change % | Portfolio Weight | Position Value | Filing Period |
|---|---|---|---|---|---|---|---|
| CRS | 1,330,920 | $394.15 | Reduced | -14.30% | 5.82% | $524.58M | 2026 Q1 |
| AMZN | 2,363,334 | $208.27 | Reduced | -59.89% | 5.46% | $492.21M | 2026 Q1 |
| IBKR | 6,275,179 | $67.07 | Reduced | -9.57% | 4.67% | $420.88M | 2026 Q1 |
| APH | 2,871,353 | $126.35 | Reduced | -22.56% | 4.03% | $362.8M | 2026 Q1 |
| EMBJ | 2,975,231 | $59.34 | Reduced | -9.24% | 1.96% | $176.55M | 2026 Q1 |
| FERG | 634,258 | $233.26 | Reduced | -37.10% | 1.64% | $147.95M | 2026 Q1 |
| RNR | 317,308 | $297.23 | Reduced | -35.33% | 1.05% | $94.31M | 2026 Q1 |
| NYT | 971,884 | $83.73 | Reduced | -31.07% | 0.90% | $81.38M | 2026 Q1 |
Total 1 Page